5936-full
Cassiopeia
Sex: F
Data Quality: 0 stars
MS: 11 yrs
Type: Relapsing-Remitting
Sensation: Moderate
Overall: Mild
Cognition: moderate
Vision: mild
Speech: mild
Swallowing: mild
Upper limb: mild
Walking: moderate
Cassiopeia
Female, 33 years
Jacksonville, FL
Primary Condition
MS
Type
Relapsing-Remitting
First symptom
Diagnosis
See more

Treatment charts require Flash. If you have problems installing Flash, visit the FAQ for help.

Get Adobe Flash player

Cassiopeia's Rebif is for:

  • MS

Cassiopeia's side effects of Rebif:

Cassiopeia's Rebif History (Stopped)
Rebif (interferon beta-1a subq injection)
3 x 44 mcg/0.5 mL Weekly Oct 06 - Nov 14, 2008
3 x 44 mcg/0.5 mL Weekly Nov 14, 2008 - Oct 16, 2009
Stopped Oct 16, 2009
Evaluations
Date Dosage MS (Multiple Sclerosis) Perceived effectiveness Side Effects Adherence Burden
Oct 16, 2009 3 x 44 mcg/0.5 mL Weekly ? SevereSevereSevereSevere UsuallyUsuallyUsuallyUsually VeryVeryVeryVery
Oct 13, 2008 3 x 44 mcg/0.5 mL Weekly ? ModerateModerateModerateModerate AlwaysAlwaysAlwaysAlways A littleA littleA littleA little

About Rebif (Prescription Drug)

Rebif, a brand name for interferon beta-1a, is an immunomodulator used to prevent episodes of symptoms and slow the development of disability in patients with relapsing-remitting multiple sclerosis. It is given subcutaneously (under the skin) three times a week, ideally the same 3 days each week.

Learn more about Rebif in our Rebif Community Report.